CPIG
ECYT

Chicago Partners Investment Group’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Chicago Partners Investment Group’s Portfolio ECYT Stock Details ECYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-1,000
Closed -$1K – 987
2017
Q3 		$1K Buy
+1,000
New +$1.39K ﹤0.01% 947
2017
Q2 		– Sell
-1,000
Closed -$3K – 844
2017
Q1 		$3K Buy
+1,000
New +$2.31K ﹤0.01% 518

Other funds holding ECYT

PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Chicago Partners Investment Group's ECYT Position: Q4 2017 in Review

Chicago Partners Investment Group sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2017, closing a stake of 1,000 shares — an estimated $1K sold.

Chicago Partners Investment Group first reported a position in ECYT in Q1 2017 and held it in 2 quarters. The position peaked at $3K in Q1 2017. 71 funds tracked by Wall St. Rank hold ECYT as of Q4 2017.

  • Chicago Partners Investment Group reported no remaining Endocyte, Inc. Common Stock position as of Q4 2017 after selling out during the quarter.
  • Chicago Partners Investment Group sold 1,000 Endocyte, Inc. Common Stock shares in Q4 2017, an estimated $1K.
  • Chicago Partners Investment Group first reported a position in Endocyte, Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Chicago Partners Investment Group's Endocyte, Inc. Common Stock position peaked at $3K in Q1 2017.
  • 71 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2017.

Based on Chicago Partners Investment Group's 13F filing for Q4 2017, filed 28 Mar 2018.